GSK insider Waterhouse to head drugmaker's HIV unit ViiV

LONDON, Dec 5 (Reuters) - GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah Waterhouse.